MenüForum-NavigationForumMitgliederAnmeldenRegistrierenForum-Breadcrumbs - Du bist hier:ForumFlohmarkt: Allgemeines0jzhyaAntwortenAntworten: 0jzhya <blockquote><div class="quotetitle">Zitat von Gast am 31. März 2026, 11:13 Uhr</div>Hello! This post was created with XRumer 23 StrongAI. Good luck :) https://basket.com.ua/ [url=https://tsn.ua/ru ]Basketball2[/url] variant4 [url=]Zoya Demidenko[/url]: Researcher in Oncology Science [url=]Zoya Demidenko[/url] is a distinguished scholar connected with the Division of Cell Stress Biology at Roswell Park Comprehensive Cancer Center in Buffalo, New York. Before that, she was employed at the NIH and New York Medical College, developing a solid background in life science study. Her scholarly work covers multiple key areas, among them the PI3K/AKT/mTOR signaling cascade, cellular cycle management, cell senescence, and malignancy biology. Currently, she has written more than 46 scientific articles, which have garnered over 4,100 references — a reflection to the impact of her work. One of her key achievements lies in elucidating the processes of biological cell aging. Her work demonstrated that when the cellular division cycle is blocked while cellular expansion continues, the cells undergo senescence. Importantly, [url=]Zoya Demidenko[/url] established that this process is pharmacologically suppressed using substances such as mTOR inhibitors. [url=]Zoya Demidenko[/url] has furthermore added substantially to tumor management investigation, particularly in the field of selective cell protection — a method designed to safeguarding normal cells from chemotherapy whilst leaving tumor cells susceptible. This strategy carries considerable promise for diminishing the toxic effects of cancer treatment. Across her professional journey, Demidenko has partnered with leading researchers globally, including Dr. Mikhail Blagosklonny. Her publications appears in leading periodicals such as Oncotarget, Cell Cycle, Aging (Albany NY), and Oncogene.</blockquote><br> Abbrechen
